Cargando…
THU616 Analysis Of Germline Mutations In Patients With Sporadic Adrenocortical Carcinoma
Disclosure: M. Terzolo: None. S. Grisanti: None. M. Scatolini: None. P. Tomaiuolo: None. E. Grosso: None. V. Basile: None. D. Cosentini: None. S. Puglisi: None. M. Laganà: None. P. Perotti: None. L. Saba: None. E. Rossini: None. S. Sigala: None. M. Volante: None. A. Berruti: None. Background: Adreno...
Autores principales: | Terzolo, Massimo, Grisanti, Salvatore, Scatolini, Maria, Tomaiuolo, Pasquale, Grosso, Enrico, Basile, Vittoria, Cosentini, Deborah, Puglisi, Soraya, Laganà, Marta, Perotti, Paola, Saba, Laura, Rossini, Elisa, Sigala, Sandra, Volante, Marco, Berruti, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555811/ http://dx.doi.org/10.1210/jendso/bvad114.146 |
Ejemplares similares
-
THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2023) -
THU620 Metastatic Adrenocortical Carcinoma Arising From A Testicular Rest Tumor
por: Chozet, Luis Edmundo, et al.
Publicado: (2023) -
OR12-1 Activity of Abiraterone Acetate in the management of Cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial.
por: Abate, Andrea, et al.
Publicado: (2022) -
THU609 Timeline For Undetectable Mitotane Plasma Levels In Adrenocortical Carcinoma Patients After Stopping Treatment
por: Younes, Nada, et al.
Publicado: (2023) -
THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)